Application of Hierarchical Bayesian Linear Model in Meta-Analysis

Meta-analysis is an evidence based tool for combining results from independent studies to obtain a concise estimate. Broadly the two parametric statistical models used in this method are the fixed effect model and the random effect model. The appropriateness of these models in incorporating variability between studies and resolving the problem of unpublished studies in meta-analysis has long been debated among statisticians. The Bayesian inference has been adopted extensively in clinical decision making. This communication provides a detailed account of the theory of Hierarchical Bayesian Linear Model (HBLM) in determining the summary estimates in meta-analysis of clinical trials. It has been shown that HBLM is a generalized model from which the results of the classical fixed effect and random effect model can be derived by treating the value of variation between studies, as either 0 or the non-iterative estimate by the methods of moments. It also provides a method for estimating the study specific estimate that helps in computing predictive probabilities. The Bayesian model has been found to be more useful in incorporating other sources of variation as it is based on Generalized Linear model.

[1]  Milton Abramowitz,et al.  Handbook of Mathematical Functions with Formulas, Graphs, and Mathematical Tables , 1964 .

[2]  R. Wolpert,et al.  Likelihood Principle , 2022, The SAGE Encyclopedia of Research Design.

[3]  B J Biggerstaff,et al.  Bayesian meta-analysis, with application to studies of ETS and lung cancer. , 1996, Lung cancer.

[4]  H. Jeffreys,et al.  The Theory of Probability , 1896 .

[5]  Park M. Reilly The Numerical Computation of Posterior Distributions in Bayesian Statistical Inference , 1976 .

[6]  A Donner,et al.  A Bayesian approach to the interpretation of subgroup results in clinical trials. , 1982, Journal of chronic diseases.

[7]  D. Spiegelhalter,et al.  The Assessment of the Subjective Opinion and its Use in Relation to Stopping Rules for Clinical Trials , 1983 .

[8]  J. Carlin Meta-analysis for 2 x 2 tables: a Bayesian approach. , 1992, Statistics in medicine.

[9]  Thomas A. Louis,et al.  Graphical Elicitation of a Prior Distribution for a Clinical Trial , 1993 .

[10]  D. Lindley,et al.  Bayes Estimates for the Linear Model , 1972 .

[11]  R. Wears,et al.  An introduction to the Bayesian analysis of clinical trials. , 1993, Annals of emergency medicine.

[12]  Canner Pl Aspirin in coronary heart disease. Comparison of six clinical trials. , 1983 .

[13]  S. Raudenbush,et al.  Empirical Bayes Meta-Analysis , 1985 .

[14]  J. Naylor,et al.  Applications of a Method for the Efficient Computation of Posterior Distributions , 1982 .

[15]  L Wasserman,et al.  Robust Bayesian methods for monitoring clinical trials. , 1995, Statistics in medicine.

[16]  D J Spiegelhalter,et al.  Bayesian approaches to random-effects meta-analysis: a comparative study. , 1995, Statistics in medicine.

[17]  D J Spiegelhalter,et al.  The CHART trials: Bayesian design and monitoring in practice. CHART Steering Committee. , 1994, Statistics in medicine.

[18]  David J. Spiegelhalter,et al.  Bayesian Approaches to Randomized Trials , 1994, Bayesian Biostatistics.